Making Science Valuation
| ALMKS Stock | EUR 8.20 0.10 1.20% |
At this time, the firm appears to be fairly valued. Making Science Group secures a last-minute Real Value of €8.46 per share. The latest price of the firm is €8.2. Our model forecasts the value of Making Science Group from analyzing the firm fundamentals such as Current Valuation of 183.15 M, return on equity of 92.95, and Profit Margin of 2.62 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Making Science's price fluctuation is not too volatile at this time. Calculation of the real value of Making Science Group is based on 3 months time horizon. Increasing Making Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Making Science's intrinsic value may or may not be the same as its current market price of 8.20, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.2 | Real 8.46 | Hype 8.2 |
The intrinsic value of Making Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Making Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Making Science Group helps investors to forecast how Making stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Making Science more accurately as focusing exclusively on Making Science's fundamentals will not take into account other important factors: Making Science Total Value Analysis
Making Science Group is presently projected to have takeover price of 183.15 M with market capitalization of 204.81 M, debt of 13.92 M, and cash on hands of 12.35 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Making Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
183.15 M | 204.81 M | 13.92 M | 12.35 M |
Making Science Investor Information
About 82.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 127.19. Making Science Group had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Making Science's historical financial statements, Making Science Group is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Making Science Asset Utilization
One of the ways to look at asset utilization of Making is to check how much profit was generated for every dollar of assets it reports. Making Science Group makes use of its assets almost 4.67 %, making €0.0467 for each euro of assets held by the firm. A positive asset utilization conveys that the company is slightly more effective with each euro of assets it secures. Strictly speaking, asset utilization of Making Science shows how effective it operates for each euro spent on its assets.Making Science Ownership Allocation
The market capitalization of Making Science Group is €204.81 Million. Making Science Group secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.19 % of Making Science Group outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.Making Science Profitability Analysis
The company reported the revenue of 58.87 M. Net Income was 1.54 M with profit before overhead, payroll, taxes, and interest of 48.72 M.About Making Science Valuation
The stock valuation mechanism determines Making Science's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Making Science Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Making Science. We calculate exposure to Making Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Making Science's related companies.Making Science Group, S.A. provides marketing and technology services in the areas of digital marketing, business analytics, electronic commerce, and cloud worldwide. The company was incorporated in 2001 and is based in Madrid, Spain. MAKING SCIENCE operates under Advertising Agencies classification in France and is traded on Paris Stock Exchange. It employs 282 people.
8 Steps to conduct Making Science's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Making Science's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Making Science's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Making Science's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Making Science's revenue streams: Identify Making Science's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Making Science's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Making Science's growth potential: Evaluate Making Science's management, business model, and growth potential.
- Determine Making Science's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Making Science's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Making Stock Analysis
When running Making Science's price analysis, check to measure Making Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Making Science is operating at the current time. Most of Making Science's value examination focuses on studying past and present price action to predict the probability of Making Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Making Science's price. Additionally, you may evaluate how the addition of Making Science to your portfolios can decrease your overall portfolio volatility.